Research Article
Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
Figure 6
CVB-D alleviates DOX-induced decrease of GSH/GSSG ratio. versus the control group; versus the DOX group, .